NBW Capital LLC Lowers Holdings in HealthEquity, Inc. (NASDAQ:HQY)

NBW Capital LLC decreased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 11.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 79,163 shares of the company’s stock after selling 10,493 shares during the quarter. HealthEquity comprises about 1.4% of NBW Capital LLC’s investment portfolio, making the stock its 27th biggest holding. NBW Capital LLC’s holdings in HealthEquity were worth $7,596,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in HQY. Wasatch Advisors LP raised its stake in shares of HealthEquity by 6.6% in the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after purchasing an additional 483,269 shares during the last quarter. Vaughan Nelson Investment Management L.P. raised its stake in shares of HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares during the last quarter. Barclays PLC raised its stake in shares of HealthEquity by 209.3% in the third quarter. Barclays PLC now owns 166,492 shares of the company’s stock worth $13,628,000 after purchasing an additional 112,667 shares during the last quarter. Thrivent Financial for Lutherans raised its stake in shares of HealthEquity by 33.3% in the third quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock worth $24,033,000 after purchasing an additional 73,404 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of HealthEquity in the third quarter worth $5,675,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $104.82 on Tuesday. The stock has a 50-day simple moving average of $105.13 and a two-hundred day simple moving average of $93.67. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market capitalization of $9.08 billion, a PE ratio of 96.17, a P/E/G ratio of 1.60 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the business posted $0.40 EPS. Analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Wall Street Analyst Weigh In

HQY has been the subject of several recent analyst reports. The Goldman Sachs Group initiated coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target for the company. Barrington Research lifted their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. Finally, Wells Fargo & Company lifted their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $113.54.

Insider Activity

In other news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the transaction, the director now owns 66,469 shares in the company, valued at $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 39,000 shares of company stock worth $3,895,788 over the last ninety days. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.